Fast-acting, inhalable insulin is growing in popularity among American adults with diabetes, local Minnesota outlet Fox 9 reported Feb. 1.

A patient’s degree of frailty could predict their functional outcomes in the year following transcatheter or surgical aortic valve repair (TAVR or SAVR), according to research out of Beth Israel Deaconess Medical Center in Boston.

Survival rates for patients treated with Abiomed’s Impella RP right ventricular assist device have been much lower in a postapproval study than they were during the device’s premarket clinical trials, the FDA said Feb. 4 in a letter to physicians.  

Researchers from the Thayer School of Engineering at Dartmouth College have developed a dime-sized innovation they claim converts the heart’s energy into electricity to power implantable devices like pacemakers and defibrillators, potentially saving cardiovascular patients the time, money and stress of repeat surgery.

IRVINE, Calif., Feb. 4, 2019 — Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study which evaluates the company's QDOT MICRO Radiofrequency (RF) Ablation Catheter used for the treatment of symptomatic drug-refractory paroxysmal atrial fibrillation (AF).

Researchers predicted 12,400 additional deaths from cardiovascular disease (CVD) could occur in England between 2021 and 2030 if the United Kingdom severs preferential trading agreements with the European Union (EU) and prices of fruits and vegetables are impacted.

E-cigarette users can now add stroke to the list of risks they incur when they make the choice to vape, according to a study of more than 400,000 Americans.

CVS Health announced Feb. 4 it will be offering free “Know Your Numbers” heart health screenings every Thursday this month—including Valentine’s Day—in an effort to boost CVD prevention across the country.

Atrial fibrillation (AF) is rare during dobutamine stress echocardiography (DSE), a routine exam for assessing coronary ischemia, but elderly patients and those with a history of paroxysmal AF are at an increased risk for arrhythmia during the test, a team of researchers from Boulogne, France, reported.

A Journal of the American Heart Association study focused on the programming safety of cardiac implantable electronic devices (CIEDs) suggests the publication of clinically meaningful trial results and professional recommendations translates poorly into real-world practice, penetrating just a fraction of a field that might benefit from added guidance.